GTR 89191150
Bids Are Invited For Price Registration For The Installment Purchase Of Medicines And Hospital Materials, To Meet The Demand Of The Municipalities In Consortium With Cisa, And Also For Use In Services Provided At Cisa, In Accordance With The Specifications Contained In The Term Of Reference That Forms Part Of This Notice As Annex I. The Winner Will Be Declared Of The Competition, The Company That Presents The Lowest Price Per Item.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
89191150
Tendering Authority
Subscribe to view
Tender No
8/2024
Financer Name
Self-Funded
Work Title
Bids Are Invited For Price Registration For The Installment Purchase Of Medicines And Hospital Materials, To Meet The Demand Of The Municipalities In Consortium With Cisa, And Also For Use In Services Provided At Cisa, In Accordance With The Specifications Contained In The Term Of Reference That Forms Part Of This Notice As Annex I. The Winner Will Be Declared Of The Competition, The Company That Presents The Lowest Price Per Item.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
04-12-2024
Closed
Work Detail
Acebrophylline, Concentration:10 Mg/Ml, Pharmaceutical Form:Syrup, 120 Ml Adult -, Concentration:5 Mg/Ml, 120 Ml Children -, Acetylcysteine 20Mg/Ml Syrup, Acetylcysteine, Dosage:200 Mg, Indication:Powder For Oral Solution - Envelope, Acetylcysteine, Dosage: 600Mg, Indication: Powder For Oral Solution, 11/27/2024, Acyclovir, Dosage:200 Mg -, Dosage:50 Mg/G, Use:Cream, 10 G -, Acetylsalicylic Acid, Dosage:100 Mg -, Ascorbic Acid, Dosage: 100 Mg/Ml, Type Of Use: Injectable, 5 Ml, Dosage: 200 Mg/Ml, Type Of Use: Oral Solution, 20 Ml- Drops, Folic Acid, Dosage:5 Mg -, Tranexamic Acid, Dosage:50 Mg/Ml, Pharmaceutical Form:Injectable Solution, Valproic Acid, Dosage: 250 Mg -, Adenosine, Dosage:3 Mg/Ml, Injectable Solution, 2 Ml, Distilled Water For Autoclave - 5 Liters, Distilled Water, Physical Aspect: Sterile And Non-Pyrogenic, 10 Ml -, 5 Ml -, Albendazole, Dosage:40 Mg/Ml, Use:Oral Suspension, Dosage:400 Mg -, Alcohol 70% - 1,000Ml, Sodium Alendronate, Dosage:70 Mg -, Alogliptin, Composition:Associated With Pioglitazone, Concentration:25 Mg + 30 Mg -, Concentration:25 Mg - Comp, Allopurinol, Dosage:300 Mg -, Alprazolam, Dosage:1 Mg -, Ambroxol, Composition: Hydrochloride Salt, Concentration:3 Mg/Ml, Form Pharmaceutical:Syrup, 120 Ml, Pediatric -, Concentration:6 Mg/Ml, Adult -, Amikacin Sulfate, Dosage:250 Mg/Ml, Indication:Injectable Solution, 2 Ml -, Aminophylline, Dosage:24 Mg/Ml, Amiodarone ( Hydrochloride), Dosage:100Mg -, Dosage:50Mg/Ml, Indication:Injectable, 3 Ml -, Amitriptyline Hydrochloride, 25 Mg -, 75 Mg -, Amoxicillin, Active Ingredient:Associated With Potassium Clavulanate, Concentration:500Mg + 125Mg -, Concentration:500Mg -, Concentration: 50Mg/Ml, Presentation: Powder For Oral Suspension, 150 Ml -, Active Ingredient Associated With Potassium Clavulanate, Convention 50 Mg/Ml + 12.5/Ml, Pharmaceutical Form Oral Suspension, 75 Ml -, Ampicillin (Sodium), Dosage: 1 G, Type Of Use: Injectable -, Amlodipine Besylate, Apixaban, Concentration:2.5 Mg -, Concentration:5 Mg -, Aripiprazole, Concentration:10 Mg -, Concentration:15 Mg -, Atenolol, Presentation:Associated With Chlorthalidone, Concentration:50Mg + 12.5Mg -, Dosage:25 Mg - , Dosage:50 Mg -, Atorvastatin Calcium, Dosage:10 Mg -, Dosage:20 Mg -, Atropine Sulfate, Dosage:0.25 Mg/Ml, Usage:Injectable Solution, 1 Ml -, 50 Mg/Ml, Azathioprine, Concentration:50 Mg -, Azithromycin (Di-Hydrate) Dosage: 40Mg/Ml Presentation: Oral Suspension, 15 Ml, Azithromycin, Dosage:500 Mg -, Baclofen, 10 Mg -, Beclomethasone 250 Mcg Spray With 200 Doses, Beclomethasone Dipropionate, Nasal Spray Presentation, Dosage 50Mcg/Dose, Additional Features Dosing Bottle With Nasal Aerator, 200 Doses, Dosage:200 Mcg, Additional Features :Capsules Inhalation, With Inhaler, 200 Doses -, Benzylpenicillin, Presentation:Benzatine, Dosage:1,200,000Ui, Use:Injectable -, Dosage:600,000Ui, Presentation:Potassic, Composition:Associated With Procained Penicillin, Dosage:100,000Ui + 300,000Ui, Use: Injectable, Benzyl Benzoate, Dosage: 25%, Pharmaceutical Form: Topical Emulsion, 60 Ml, Betahistine Dihydrochloride, 16 Mg -, Concentration: 24 Mg -, Betamethasone, Composition: Acetate, Presentation: Associated With Betamethasone Phosphate, Dosage :3Mg + 3Mg/Ml, Composition:Dipropionate, Dosage:5Mg + 2Mg, Presentation:Associated With Gentamicin Sulfate, 5Mg + 1Mg/G, Use:Ointment, 30 G -, Associated With Ketoconazole And Neomycin, Concentration:0.5 Mg/G + 20 Mg/G + 1.5 Mg/G, Pharmaceutical Form: 30G Ointment, Composition: Phosphate, Dosage: 4 Mg/Ml, Sodium Bicarbonate, 8.4%, Biperi
Key Value
Tender Value
15,283,953 - BRL
Tender Documents
Global Tender Document
0f27be36-ff9a-4f1a-b269-91a1dd5cea83.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.